Bill Plovanic

Bill Plovanic is a seasoned professional with extensive experience in the medical technology industry.

He currently serves as the Managing Director and Equity Research Medical Technology Analyst at Canaccord Genuity-Global Capital Markets.

With a rich background, Bill has held key positions at various organizations, including Obalon Therapeutics, where he was a Board Member, President, CEO, and Chief Financial Officer.

His expertise also extends to his role as Managing Director of Equity Research at First Albany Capital.

Bill's broad industry knowledge and leadership skills have made him a highly respected figure in the field of medical technology and equity research.

His diverse roles have equipped him with a deep understanding of the market dynamics and trends in the healthcare sector.

Throughout his career, Bill Plovanic has demonstrated a strong dedication to driving innovation and growth within the medical technology space.